Cargando…

Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing

Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Billaud, Amandine, Verriele, Veronique, Dauvé, Jonathan, Chevalier, Louise-Marie, Morel, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/
https://www.ncbi.nlm.nih.gov/pubmed/32751202
http://dx.doi.org/10.3390/diagnostics10080527
_version_ 1783576626132418560
author Billaud, Amandine
Verriele, Veronique
Dauvé, Jonathan
Chevalier, Louise-Marie
Morel, Alain
author_facet Billaud, Amandine
Verriele, Veronique
Dauvé, Jonathan
Chevalier, Louise-Marie
Morel, Alain
author_sort Billaud, Amandine
collection PubMed
description Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes. Consequently, studies have focused on refining the characterization of biomarkers, especially concerning the resistance mutation p.Thr790Met of EGFR. Herein, we developed peptide nucleic acid (PNA)-mediated PCR clamping followed by pyrosequencing, favoring enrichment of the mutated fraction. A preamplification step was first added to increase the amplifiable DNA fraction. Throughout the application of our method on DNA extracted from FFPE samples of 46 patients with NSCLC who had relapsed under first-generation EGFR TKI, we evaluated a sensitivity of 93.3% and a specificity of 100%. All 19 patients who were positive for the p.Thr790Met mutation with NGS were also found to be positive with our protocol. The only discordant case was a sample with no mutation detected with NGS, but which was positive with PNA. This protocol allows for the detection of the p.Thr790Met mutation with a sensitivity of 0.5% which will permit earlier detection and an improvement of therapeutic management.
format Online
Article
Text
id pubmed-7460542
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74605422020-09-03 Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing Billaud, Amandine Verriele, Veronique Dauvé, Jonathan Chevalier, Louise-Marie Morel, Alain Diagnostics (Basel) Article Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes. Consequently, studies have focused on refining the characterization of biomarkers, especially concerning the resistance mutation p.Thr790Met of EGFR. Herein, we developed peptide nucleic acid (PNA)-mediated PCR clamping followed by pyrosequencing, favoring enrichment of the mutated fraction. A preamplification step was first added to increase the amplifiable DNA fraction. Throughout the application of our method on DNA extracted from FFPE samples of 46 patients with NSCLC who had relapsed under first-generation EGFR TKI, we evaluated a sensitivity of 93.3% and a specificity of 100%. All 19 patients who were positive for the p.Thr790Met mutation with NGS were also found to be positive with our protocol. The only discordant case was a sample with no mutation detected with NGS, but which was positive with PNA. This protocol allows for the detection of the p.Thr790Met mutation with a sensitivity of 0.5% which will permit earlier detection and an improvement of therapeutic management. MDPI 2020-07-29 /pmc/articles/PMC7460542/ /pubmed/32751202 http://dx.doi.org/10.3390/diagnostics10080527 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Billaud, Amandine
Verriele, Veronique
Dauvé, Jonathan
Chevalier, Louise-Marie
Morel, Alain
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title_full Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title_fullStr Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title_full_unstemmed Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title_short Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
title_sort non-small-cell lung cancer-sensitive detection of the p.thr790met egfr alteration by preamplification before pna-mediated pcr clamping and pyrosequencing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/
https://www.ncbi.nlm.nih.gov/pubmed/32751202
http://dx.doi.org/10.3390/diagnostics10080527
work_keys_str_mv AT billaudamandine nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing
AT verrieleveronique nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing
AT dauvejonathan nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing
AT chevalierlouisemarie nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing
AT morelalain nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing